Lexeo Therapeutics Ratios (2022-2023) | LXEO

Ratios Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Profitability
EBT Margin -3,211.86%26,994.44%37,314.00%25,360.38%38,669.23%28,374.00%
EBIT Margin -3,292.28%28,142.59%38,580.00%26,367.92%38,986.54%29,948.00%
EBITDA Margin -3,292.28%28,142.59%38,580.00%26,367.92%38,986.54%29,948.00%
Operating Margin -3,292.28%28,142.59%38,580.00%26,367.92%38,986.54%29,948.00%
Net Margin -3,211.86%26,994.44%37,314.00%25,360.38%38,669.23%28,374.00%
FCF Margin 30,835.19%36,772.00%24,969.81%26,861.54%28,046.00%
Efficiency
Equity Average -105.97M
Invested Capital -98.98M-112.95M-162.81M
Leverage & Solvency
Interest Coverage Ratio -602.83-281.43-385.80-263.68-389.87-299.48
Equity Ratio -1.16-2.98
Times Interest Earned -602.83-281.43-385.80-263.68-389.87-299.48
Valuation
Enterprise Value -94.15M-77.33M-35.45M357.58M
Market Capitalization 357.58M
Return Ratios
Return on Sales -170.40%319.54%323.87%